Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 5/20 | 0.34 |
| ▸ | CHRNA4 | P43681 | 5/20 | 0.34 |
| ▸ | CHRNB4 | P30926 | 3/20 | 0.34 |
| ▸ | CHRNA3 | P32297 | 3/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11391992 | 0.83 | CHRNB2 (0.34) | CHRNB2CHRNA4CHRNB4CHRNA3ALOX15 | |
| SCHEMBL1469331 | 0.82 | CHRNB2 (0.36) | CHRNB2CHRNA4CHRNB4CHRNA3ALOX15 | |
| SCHEMBL11128650 | 0.80 | CHRNB2 (0.35) | CHRNB2CHRNA4CHRNB4CHRNA3ALOX15 | |
| SCHEMBL11128665 | 0.80 | CHRNB2 (0.35) | CHRNB2CHRNA4CHRNB4CHRNA3ALOX15 | |
| SCHEMBL31685161 | 0.80 | ALOX15 (0.48) | CHRNB2CHRNA4CHRNB4CHRNA3ALOX15 | |
| SCHEMBL1128701 | 0.80 | CHRNB2 (0.37) | CHRNB2CHRNA4CHRNB4CHRNA3ALOX15 | |
| SCHEMBL36334 | 0.80 | ALOX15 (0.48) | CHRNB2CHRNA4CHRNB4CHRNA3ALOX15 | |
| SCHEMBL5836653 | 0.79 | ALOX15 (0.47) | CHRNB2CHRNA4CHRNB4CHRNA3ALOX15 | |
| SCHEMBL217499 | 0.79 | — | — | |
| SCHEMBL20581917 | 0.79 | TSHR (0.44) | CHRNB2CHRNA4CHRNB4CHRNA3ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4635941-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | Nouryon Chemicals International B.V. (NL) | 2025-10-22 | — | — | EP | claimed |
| EP-4471010-B1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | NOURYON CHEMICALS INT BV (NL) | 2025-06-04 | — | — | EP | claimed |
| US-20240400490-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2024-12-05 | — | — | US | claimed |
| EP-4471010-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | Nouryon Chemicals International B.V. (NL) | 2024-12-04 | — | — | EP | claimed |
| CN-119059951-A | Process for preparing peroxyesters or peroxycarbonates | 诺力昂化学品国际有限公司 | 2024-12-03 | — | — | CN | claimed |
| EP-4635941-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | Nouryon Chemicals International B.V. (NL) | 2025-10-22 | — | — | EP | disclosed |
| EP-4471010-B1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | NOURYON CHEMICALS INT BV (NL) | 2025-06-04 | — | — | EP | disclosed |
| US-20240400490-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2024-12-05 | — | — | US | disclosed |
| EP-4471010-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | Nouryon Chemicals International B.V. (NL) | 2024-12-04 | — | — | EP | disclosed |
| CN-119059951-A | Process for preparing peroxyesters or peroxycarbonates | 诺力昂化学品国际有限公司 | 2024-12-03 | — | — | CN | disclosed |
| CN-109384699-B | On-line full continuous flow production process for directly preparing organic peroxide by taking hydrogen peroxide as raw material | 上海惠和化德生物科技有限公司 | 2024-10-22 | — | — | CN | disclosed |
| US-10947189-B2 | Online continuous flow process for the synthesis of organic peroxides using hydrogen peroxide as raw material | SHANGHAI HYBRID-CHEM TECHNOLOGIES (CN) | 2021-03-16 | — | — | US | disclosed |
| US-6482970-B1 | Peroxides, their preparation process and use | AKZO NOBEL NV (NL) | 2002-11-19 | — | — | US | disclosed |
| EP-1233014-A1 | ASYMMETRIC ORGANIC PEROXIDE, CROSSLINKING AGENT COMPRISING THE SAME, AND METHOD OF CROSSLINKING WITH THE SAME | NOF CORPORATION (JP) | 2002-08-21 | — | — | EP | disclosed |
| EP-1220837-A1 | PROCESS FOR PREPARING PEROXIDES USING MIXED ANHYDRIDES | Akzo Nobel N.V. (NL) | 2002-07-10 | — | — | EP | disclosed |
| WO-2001027078-A1 | PROCESS FOR PREPARING PEROXIDES USING MIXED ANHYDRIDES | AKZO NOBEL N.V. (NL) | 2001-04-19 | — | — | WO | disclosed |
| EP-1071662-A1 | PEROXIDES, THEIR PREPARATION PROCESS AND USE | Akzo Nobel N.V. (NL) | 2001-01-31 | — | — | EP | disclosed |
| EP-1049668-A1 | KETONE PEROXIDE DERIVATIVES, THEIR PREPARATION AND USE | Akzo Nobel N.V. (NL) | 2000-11-08 | — | — | EP | disclosed |
| WO-1999052864-A1 | PEROXIDES, THEIR PREPARATION PROCESS AND USE | AKZO NOBEL N.V. (NL) | 1999-10-21 | — | — | WO | disclosed |
| WO-1999032442-A1 | KETONE PEROXIDE DERIVATIVES, THEIR PREPARATION AND USE | AKZO NOBEL N.V. (NL) | 1999-07-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10947189-B2 | Online continuous flow process for the synthesis of organic peroxides using hydrogen peroxide as raw material | PPOX, HAO2, AOX1 | CHRNB2 4411/4885CHRNA4 4510/4885CHRNB4 4363/4885 |
| US-20240400490-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | GPX4, PRDX4, PRDX2 | CHRNB2 3592/4885CHRNA4 3560/4885CHRNB4 2712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.